Phocas Financial Corp’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-293,538	Closed	-$1.25M	–	176
2023 Q2	$1.25M	Buy	293,538 +130,398	+80%	+$769K	0.17%	128
2023 Q1	$1.12M	Buy	+163,140	New	+$1.27M	0.16%	129
2022 Q3	–	Sell	-316,455	Closed	-$2.29M	–	203
2022 Q2	$2.29M	Sell	316,455 -67,555	-18%	-$587K	0.34%	113
2022 Q1	$4.96M	Sell	384,010 -130,428	-25%	-$1.66M	0.62%	72
2021 Q4	$8.21M	Buy	514,438 +9,502	+2%	+$166K	1.05%	33
2021 Q3	$8.11M	Buy	504,936 +253,578	+101%	+$3.72M	1.03%	29
2021 Q2	$3.48M	Buy	251,358 +49,730	+25%	+$704K	0.44%	92
2021 Q1	$2.95M	Buy	201,628 +99,013	+96%	+$1.68M	0.39%	103
2020 Q4	$1.78M	Sell	102,615 -20,847	-17%	-$371K	0.27%	114
2020 Q3	$2.26M	Buy	123,462 +3,946	+3%	+$73.4K	0.39%	108
2020 Q2	$2.13M	Sell	119,516 -10,343	-8%	-$175K	0.38%	113
2020 Q1	$2.11M	Buy	129,859 +16,311	+14%	+$301K	0.42%	101
2019 Q4	$2.04M	Buy	+113,548	New	+$2.09M	0.25%	117